You are here
Press Releases
2021
The CEO Roundtable on Cancer has accredited BeiGene, Ltd., a global biotechnology company with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
Project Data Sphere’s open access data platform has achieved a major milestone: Boosting the impact of oncology research by contributing to publication of more than 100 peer-reviewed articles that impact research and clinical practice.
CARY, NC (March 25, 2021) -- The CEO Roundtable on Cancer has elected to its Board of Directors Dr. Belén Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck KGaA, Darmstadt, Germany, and Dr. Peter WT Pisters, president of The University of Texas MD Anderson Cancer Center.
Dr. Martin J. Murphy has retired from the Board of Directors of the CEO Roundtable on Cancer and been elected Director Emeritus.
2020
High Point University has earned CEO Cancer Gold Standard accreditation by the CEO Roundtable on Cancer for its commitment to the health of its employees, students and campus community.
The CEO Roundtable on Cancer has recognized the healthcare business of Merck KGaA, Darmstadt, Germany, operating as EMD Serono in the US and Canada, with the 2020 Dr. Charles A. Sanders Award for collaborative scientific research in cancer.
SALT LAKE CITY – Huntsman Cancer Institute (HCI) at the University of Utah has earned CEO Cancer Gold StandardTM accreditation for its work to reduce the risk of cancer for its employees and covered family members. HCI is the first employer in Utah and the five-state Mountain West to earn this prestigious designation.SALT LAKE CITY – Huntsman Cancer Institute (HCI) at the University of Utah has earned CEO Cancer Gold StandardTM accreditation for its work to reduce the risk of cancer for its employees and covered family members. HCI is the first employer in Utah and the five-state Mountain West to earn this prestigious designation.
Global biopharmaceutical company Bristol Myers Squibb, based in Princeton, NJ, has earned the prestigious global CEO Cancer Gold StandardTM accreditation for its ongoing commitment to reduce cancer risk for employees and their family members around the world.
(June 29, 2020) – The CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than seven million employees and their family members prevent and address cancer through workplace-based programming. This year, 18 Gold Standard employers mark their ten-year anniversary as Gold Standard employers, having maintained a strong commitment to the health of their employees and satisfying the latest, comprehensive requirements of the Gold Standard.
Anne Arundel Medical Center has earned CEO Cancer Gold StandardTM accreditation for its work to reduce the risk of cancer for its employees and covered family members.
2019
The CEO Roundtable on Cancer (CEORT) today announced the appointment of K. Andrew Crighton, MD to serve as chief executive officer, beginning in January 2020. Dr. Crighton will succeed founding CEO, Martin J. Murphy, DMedSc, PhD, who will remain with the organization as a member of the board of directors and leader of several vital projects.
2018
The CEO Roundtable on Cancer proudly announces the State of Colorado has earned CEO Cancer Gold Standard™ accreditation, recognizing Governor John W. Hickenlooper’s efforts to reduce the risk of cancer for state employees and covered family members.
The CEO Roundtable on Cancer Inc. honored Jean Becker, Ken Lee and Phil Porter, three leaders dedicated to cancer prevention and to speeding cancer research, with the 2018 Dr. Charles A. Sanders Life Sciences Award in recognition of their extraordinary collaboration with the CEO Roundtable on Cancer’s Life Sciences Consortium and its Project Data Sphere, LLC.
The CEO Roundtable on Cancer has accredited Aura Biosciences of Cambridge, MA — a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells — with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
2017
Initiative realizes tremendous progress in making clinical trial data and resources more broadly available and accessible to the cancer research and care community